Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac surgery patients.Study reveals ...
SeaStar Medical (ICU) announces the shipment of its QUELIMMUNE device to a prominent academic medical center, representing SeaStar Medical’s ...
DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, ...
Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...
TIN-816 is under development for the treatment of sepsis-associated acute kidney injury (SA-AKI) and acute kidney injury ...